Brooks Automation, Inc., a worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy, announced that it had completed the acquisition of the Celigo Cell Cytometer product line from Cyntellect Inc., a privately held life sciences company based in San Diego.
Introduced to the market in early 2010, Celigo has become one of the most rapidly adopted cell imaging systems based on its unique combination of high-throughput, ease-of-use, and affordability. The installed customer base for Celigo includes many of the top pharmaceutical, biotechnology, and academic institutions worldwide.
As part of the transaction, the majority of Cyntellect's employees who have supported Celigo since inception are being moved to Brooks' nearby facility in Poway, CA, providing for a seamless transition of the key engineering, manufacturing, and R&D capabilities, as well as the field based sales and support personnel.
Dr. Steve Schwartz, President and CEO of Brooks, stated, "The Celigo cellular imaging product line is an impressive addition to our family of stand-alone instrumentation products used by many of our automated sample management system life sciences customers. It joins a growing portfolio of high productivity automated solutions for the analysis, handling and testing of biological and compound samples prior to and following their storage in our automated sample management systems."
Dr. Schwartz continued, "The Celigo cell cytometer enables microplate-based high-throughput, high-content, brightfield and fluorescence cellular imaging and analysis, with minimal sample manipulation."
Saiid Zarrabian, President and CEO of Cyntellect, stated, "We are thrilled to have found a tremendous partner in Brooks to take Celigo to the next level. When combined with Brooks' world-class infrastructure, global commercial reach and worldwide customer support, Celigo will have the opportunity to penetrate markets that otherwise weren't accessible to Cyntellect. We are confident that Celigo's rapid early market penetration will be greatly accelerated by Brooks."
The purchase price was disclosed as up to approximately $9.2 million with settlement of part of the purchase price deferred for a six month period.
Source: Brooks Automation, Inc.